Cibc World Market Inc. Biomarin Pharmaceutical Inc Transaction History

Cibc World Market Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $1.59 Million - $2.14 Million	19,660 New	19,660 $2.04 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $770,877 - $1.41 Million	-10,726 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $853,253 - $1.33 Million	10,726 New	10,726 $1.32 Million
Q2 2018 Aug 08, 2018	SELL	$76.01 - $99.03 $199,146 - $259,458	-2,620 Closed	0 $0
Q4 2017 Feb 01, 2018	SELL	$80.76 - $95.13 $5,491 - $6,468	-68 Reduced 2.53%	2,620 $234,000
Q3 2017 Nov 13, 2017	BUY	$80.6 - $94.95 $216,652 - $255,225	2,688	2,688 $250,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.